Genetic variants of complement component 3 (C3) in DR4 positive and DR4 negative rheumatoid arthritis

Area of Science:

• Immunogenetics
• Rheumatology
• Complement System Biology

Background:

• Rheumatoid arthritis (RA) is an autoimmune disease with complex genetic components.
• The complement system, particularly C3, plays a role in immune responses and inflammation.
• Genetic variations like C3 allotypes may influence RA susceptibility or disease characteristics.

Purpose of the Study:

• To investigate the association between C3 allotypes and rheumatoid arthritis in a Caucasoid population.
• To compare C3 allotype and phenotype frequencies in RA patients versus healthy controls.

Main Methods:

• C3 allotypes were determined in 86 Caucasoid patients diagnosed with rheumatoid arthritis.
• C3 allotypes were also determined in 80 healthy Caucasoid individuals serving as local controls.
• Frequencies of C3 allotypes and phenotypes were statistically analyzed between patient and control groups.

Main Results:

• No significant differences were observed in the frequencies of C3 allotypes between rheumatoid arthritis patients and healthy controls.
• C3 phenotype frequencies also showed no significant variation between the studied groups.
• These findings were consistent regardless of the presence or absence of the DR4 human leukocyte antigen.

Conclusions:

• C3 allotypes are unlikely to be a significant genetic risk factor for rheumatoid arthritis in the studied Caucasoid population.
• The distribution of C3 genetic variants appears similar in individuals with and without rheumatoid arthritis.
• Further research may explore other complement components or genetic markers in relation to RA.